Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Psychology & Psychiatry

Fighting loneliness by finding purpose

A new study published in Psychology and Aging co-authored by Patrick Hill, associate professor of psychological and brain sciences, offers an important message for our times: A sense of purpose in life—whether it's a high-minded ...

Alzheimer's disease & dementia

Social contact may help preserve brain function in later life

A study of the impact of social isolation on cognitive performance and brain structure has highlighted the importance of a good social support system in maintaining a healthy brain into later life.

Medical research

Pregnancy hormone repairs myelin damage in MS mouse model

Treating a mouse model of multiple sclerosis with the pregnancy hormone estriol reversed the breakdown of myelin in the brain's cortex, a key region affected in multiple sclerosis, according to a new UCLA Health study published ...

Alzheimer's disease & dementia

Altered gut bacteria may be early sign of Alzheimer's disease

People in the earliest stage of Alzheimer's disease—after brain changes have begun but before cognitive symptoms become apparent—harbor an assortment of bacteria in their intestines that differs from the gut bacteria ...

page 16 from 40